Asthma drug debate, illustration

Asthma drug debate, illustration

C028/6272 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 78.1MB

Downloadable file size: 3.2MB

Price image Pricing

Please login to use the price calculator


Caption: Asthma drug debate. Conceptual illustration of the medical debate surrounding a class of drugs known as long-acting beta2-adrenoceptor agonists (LABAs). Figures surround a model of a LABA drug molecule inside a sphere. LABAs, which include salmeterol, formoterol and bambuterol, are usually prescribed to treat symptoms of persistent asthma and chronic obstructive pulmonary disease (COPD). LABAs are designed to reduce the need for shorter-acting drugs. However there is concern regarding their use. Although they relieve asthma symptoms they may also increase the small risk of fatal attacks, possibly by promoting bronchial inflammation and sensitivity without warning.

Release details: Model release not required. Property release not required.

Keywords: abnormal, argument, art, artwork, asthma, asthma attack, bambuterol, beta2-adrenergic receptor agonist, biological, biology, chemical compound, chemistry, chronic obstructive pulmonary disease, compound, concept, conceptual, condition, controversial, controversy, copd, crowd, danger, dangerous, death, debate, disease, disorder, drug, fatal, fatality, formoterol, health, healthcare, human, human anatomy, illustration, long acting, long-acting, medical, medication, medicine, molecular model, molecular structure, molecule, no-one, nobody, pathological, pathology, people, pharmaceutical, pharmaceutics, pharmacological, pharmacology, respiratory, risk, row, safety, salmeterol, science, scientific, side effect, treatment, unhealthy, unsafe

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.